$150.00 – $4,000.00
It is an agonist at GABA-A receptors and possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties.
Initially introduced in 1983 in Japan as treatment for neurological conditions such as anxiety and sleep disorders, etizolam is marketed in Japan, Italy and India.
It is not approved for use by FDA in the US; however it remains unscheduled in several states and is legal for research purposes. Contact online customer service for price list